|
David O. Meltzer, M.D., Ph.D.
David O. Meltzer, M.D., Ph.D. is an associate professor in the Department
of Medicine and an associated faculty member of the Harris School and
the Department of Economics. Meltzer's research explores problems in health
economics and public policy. A major area of Meltzer's research examines
the theoretical foundations of medical cost-effectiveness analysis, including
issues such as accounting for future costs due to the extension of life,
the value of research, and the effects of patient choice and preferences
on the value of medical interventions, which he has examined in the context
of diabetes and prostate cancer. Another major area of study examines
the effects of medical specialization on the cost and quality of care,
especially in teaching hospitals. Dr. Meltzer is currently principal investigator
for a randomized trial examining the use of doctors who specialize in
inpatient care ("hospitalists") compared to traditional academic
physicians in six academic medical centers. Other work examines the role
of mortality decline in the economic growth and the demographic transition
of developing countries; the effects of prospective payment systems on
the cost and quality of care, and the effects of FDA regulation on innovation
in the pharmaceutical industry.
Meltzer received his M.D. and Ph.D. in economics from the University of Chicago and completed his residency in internal medicine at Brigham and Women's Hospital in Boston. Meltzer directs the Center for Health and Social Sciences (CHeSS) at the University of Chicago and the Centers for Disease Control Chicago Center of Excellence in Health Promotion Economics. He is also co-director of the Program in Outcomes Research Training and the MD/PhD Program in the Social Sciences at the University of Chicago and serves on the faculty of the Graduate Program in Health Administration and Policy, the Population Research Center and the Center on Aging.
Meltzer is the recipient of numerous awards, including the Lee Lusted
Prize of the Society for Medical Decision Making, the Health Care Research
Award of the National Institute for Health Care Management, the John M.
Olin Faculty Fellowship, the Robert Wood Johnson Generalist Physician
Award, the Eugene Garfield Economic Impact Award from Research America,
and the Leaders in General Medicine Award from the Midwest Society for
General Internal Medicine. He is also a faculty research fellow for the
National Bureau of Economic Research and has served on a panel that is
examining the "Future of Medicare" for the National Academy
of Social Insurance, on panels examining U.S. organ allocation policy
and cord blood stem cell banking for the Institute of Medicine, and on
a Technical Advisory Panel on the financial viability of Medicare for
the Department of Health and Human Services.
|
